Actionable insights straight to your inbox

logo_equities.svg

Bristol-Myers Squibb’s Trademark Application for “NUTRAMIGEN” Filed

By a News Reporter-Staff News Editor at Pharma Business Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a trademark application has been made for

By a News Reporter-Staff News Editor at Pharma Business Week — According to news reporting originating from Washington, D.C., by NewsRx journalists, a trademark application has been made for “NUTRAMIGEN” by Nadine P. Flynn, representing Bristol-Myers Squibb. This application was made available to the public on June 27, 2014 (see also Pharmaceutical Companies).
The serial number for this application is 78746437.
The international trademark goods and services class code for this trademark application is 005. The applicant indicates that “Color is not claimed as a feature of the mark.”
As submitted by the applicant, this trademark application relates to the following goods and services: Infant formula.
The owner/registrar information for this application is: Nadine P. Flynn, Bristol-Myers Squibb, Trademark Department, 345 Park Avenue, New York, NY 10154.
Keywords for this news article include: Trademarks, Bristol-Myers Squibb, Biotechnology Companies, Biopharmaceutical Companies.
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC

Many people think of position size in terms of how many shares they own of a particular stock. But it’s much smarter to think of it in terms of what percentage of your total capital is in a particular stock.